Purple Biotech (PPBT) EPS (Diluted) (2020 - 2026)
Powered by 
Analysis
Purple Biotech (PPBT) EPS (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.24 Bn | 192.25 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 180.01 Bn | 176.83 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.33 Bn | 123.47 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 81.87 Bn | 73.87 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 60.27 Bn | 55.08 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 53.93 Bn | 48.79 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.17 Bn | 29.86 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.89 Bn | 30.60 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.12 Bn | 29.12 Bn | 1.16 Mn | -0.40 |
| 10 | Purple Biotech | 282,022.44 | 282,022.44 | - | -0.92 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.92 |
| Mar 31, 2026 | 0.18 |
| Dec 31, 2025 | 49.05 |
| Sep 30, 2025 | 7.95 |
| Jun 30, 2025 | 6.62 |
| Mar 31, 2025 | 2.76 |
| Dec 31, 2024 | 2.50 |
| Sep 30, 2024 | 5.99 |
| Jun 30, 2024 | 21.73 |
| Mar 31, 2024 | 33.99 |
| Dec 31, 2023 | 43.63 |
| Sep 30, 2023 | 55.70 |
| Jun 30, 2023 | 56.83 |
| Mar 31, 2023 | 53.96 |
| Dec 31, 2022 | 66.49 |
| Sep 30, 2022 | 54.92 |
| Jun 30, 2022 | 40.26 |
| Mar 31, 2022 | 83.07 |
| Dec 31, 2021 | 93.45 |
| Sep 30, 2021 | 54.56 |